Cargando…

743. Efficacy and persistence of 3M™ Skin and Nasal Antiseptic for reduction of S. aureus colonization ex vivo porcine tissue model

BACKGROUND: Surgical-site infections can result from nasal colonization of Staphylococcus aureus prior to surgery. Nasal decolonization with iodine-based products is a common way to combat this problem. The efficacy and persistence of nasal decolonization products is a crucial component for this pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Laubach, Isabel A, Peterson, Marnie L, Parthasarathy, Ranjani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678503/
http://dx.doi.org/10.1093/ofid/ofad500.804
_version_ 1785150377137537024
author Laubach, Isabel A
Peterson, Marnie L
Parthasarathy, Ranjani
author_facet Laubach, Isabel A
Peterson, Marnie L
Parthasarathy, Ranjani
author_sort Laubach, Isabel A
collection PubMed
description BACKGROUND: Surgical-site infections can result from nasal colonization of Staphylococcus aureus prior to surgery. Nasal decolonization with iodine-based products is a common way to combat this problem. The efficacy and persistence of nasal decolonization products is a crucial component for this presurgical protocol to be successful. An ex vivo porcine mucosal model allows for clinically relevant testing of formulations without the need for live animals. METHODS: Fresh porcine vaginal mucosa was processed to create 5 mm diameter explants. One group was left uninfected, and the other was infected with prepared methicillin-resistant S. aureus (MRSA) Xen30 to achieve 10(6) CFU/explant and incubated for 2h at 37 °C. After 2-hour incubation, explants were treated with formulation for 1h then gently washed with mucin and incubated for 24h at 37 °C. Uninfected explants were photographed prior to treatment, immediately post treatment, pre and post wash, and at hour intervals following mucin wash. Infected explants were collected into neutralizing solution at 24h, vortexed and sonicated to liberate bacteria then plated to enumerate CFU/explant. Additional infected explants were stained with LIVE/DEAD stain and imaged by fluorescence microscopy at 24h. RESULTS: Pictures of uninfected, treated explants showed that 3M™ Skin and Nasal Antiseptic (SNA) formulation persisted visually on the tissue up to 6h post wash while Betadine was no longer visible on tissue at 1h post wash. At 24h post wash, explants treated with Skin and Nasal had no recoverable colony forming units while explants treated with Betadine had regrown to ∼7 Log(10) CFU/explant. This finding was confirmed by staining and fluorescent imaging. Fluorescent imaging showed that treatment of uninfected explants with SNA or Betadine did not compromise tissue viability compared to untreated control; however, infected explants treated with Skin and Nasal retained the most tissue viability. Fluorescent images of porcine vaginal mucosa stained with LIVE/DEAD stain following 24h incubation with formulations. [Figure: see text] CONCLUSION: The material properties of SNA prep allow it to remain on the tissue even after washing resulting in longer lasting activity against MRSA Xen30 than Betadine treatment over 24 hours. By persisting, the SNA treated explants showed reduced tissue damage by MRSA than was observed in the Betadine and untreated groups. DISCLOSURES: Ranjani Parthasarathy, PhD, 3M: Have patents|3M: 3M employee|3M: Stocks/Bonds
format Online
Article
Text
id pubmed-10678503
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106785032023-11-27 743. Efficacy and persistence of 3M™ Skin and Nasal Antiseptic for reduction of S. aureus colonization ex vivo porcine tissue model Laubach, Isabel A Peterson, Marnie L Parthasarathy, Ranjani Open Forum Infect Dis Abstract BACKGROUND: Surgical-site infections can result from nasal colonization of Staphylococcus aureus prior to surgery. Nasal decolonization with iodine-based products is a common way to combat this problem. The efficacy and persistence of nasal decolonization products is a crucial component for this presurgical protocol to be successful. An ex vivo porcine mucosal model allows for clinically relevant testing of formulations without the need for live animals. METHODS: Fresh porcine vaginal mucosa was processed to create 5 mm diameter explants. One group was left uninfected, and the other was infected with prepared methicillin-resistant S. aureus (MRSA) Xen30 to achieve 10(6) CFU/explant and incubated for 2h at 37 °C. After 2-hour incubation, explants were treated with formulation for 1h then gently washed with mucin and incubated for 24h at 37 °C. Uninfected explants were photographed prior to treatment, immediately post treatment, pre and post wash, and at hour intervals following mucin wash. Infected explants were collected into neutralizing solution at 24h, vortexed and sonicated to liberate bacteria then plated to enumerate CFU/explant. Additional infected explants were stained with LIVE/DEAD stain and imaged by fluorescence microscopy at 24h. RESULTS: Pictures of uninfected, treated explants showed that 3M™ Skin and Nasal Antiseptic (SNA) formulation persisted visually on the tissue up to 6h post wash while Betadine was no longer visible on tissue at 1h post wash. At 24h post wash, explants treated with Skin and Nasal had no recoverable colony forming units while explants treated with Betadine had regrown to ∼7 Log(10) CFU/explant. This finding was confirmed by staining and fluorescent imaging. Fluorescent imaging showed that treatment of uninfected explants with SNA or Betadine did not compromise tissue viability compared to untreated control; however, infected explants treated with Skin and Nasal retained the most tissue viability. Fluorescent images of porcine vaginal mucosa stained with LIVE/DEAD stain following 24h incubation with formulations. [Figure: see text] CONCLUSION: The material properties of SNA prep allow it to remain on the tissue even after washing resulting in longer lasting activity against MRSA Xen30 than Betadine treatment over 24 hours. By persisting, the SNA treated explants showed reduced tissue damage by MRSA than was observed in the Betadine and untreated groups. DISCLOSURES: Ranjani Parthasarathy, PhD, 3M: Have patents|3M: 3M employee|3M: Stocks/Bonds Oxford University Press 2023-11-27 /pmc/articles/PMC10678503/ http://dx.doi.org/10.1093/ofid/ofad500.804 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Laubach, Isabel A
Peterson, Marnie L
Parthasarathy, Ranjani
743. Efficacy and persistence of 3M™ Skin and Nasal Antiseptic for reduction of S. aureus colonization ex vivo porcine tissue model
title 743. Efficacy and persistence of 3M™ Skin and Nasal Antiseptic for reduction of S. aureus colonization ex vivo porcine tissue model
title_full 743. Efficacy and persistence of 3M™ Skin and Nasal Antiseptic for reduction of S. aureus colonization ex vivo porcine tissue model
title_fullStr 743. Efficacy and persistence of 3M™ Skin and Nasal Antiseptic for reduction of S. aureus colonization ex vivo porcine tissue model
title_full_unstemmed 743. Efficacy and persistence of 3M™ Skin and Nasal Antiseptic for reduction of S. aureus colonization ex vivo porcine tissue model
title_short 743. Efficacy and persistence of 3M™ Skin and Nasal Antiseptic for reduction of S. aureus colonization ex vivo porcine tissue model
title_sort 743. efficacy and persistence of 3m™ skin and nasal antiseptic for reduction of s. aureus colonization ex vivo porcine tissue model
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678503/
http://dx.doi.org/10.1093/ofid/ofad500.804
work_keys_str_mv AT laubachisabela 743efficacyandpersistenceof3mskinandnasalantisepticforreductionofsaureuscolonizationexvivoporcinetissuemodel
AT petersonmarniel 743efficacyandpersistenceof3mskinandnasalantisepticforreductionofsaureuscolonizationexvivoporcinetissuemodel
AT parthasarathyranjani 743efficacyandpersistenceof3mskinandnasalantisepticforreductionofsaureuscolonizationexvivoporcinetissuemodel